Should we treat iron deficiency anaemia of pregnancy with lactoferrin? A randomised controlled trial

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Iron deficiency affects over 2 billion people, with women and children at greatest risk. Iron deficiency anaemia in pregnancy is linked with low birth weight and lower IQ and school performance in children. Current treatment with oral iron causes nausea, constipation and stomach pain in about half of women who take it. Bovine lactoferrin is a dairy protein which is safe with no side effects. This study will test promising evidence that bovine lactoferrin may be a more effective treatment for anaemia in pregnancy.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $2,748,719.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Obstetrics and Gynaecology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anaemia | epigenetics | health economics | infant development | intrauterine growth retardation | iron deficiency | neonatal survival | pregnancy outcome | quality of life | telomeres